Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

COMIRNATY ORIGINAL/OMICRON BA.1 DIN 02532018

Status: Cancelled Pre Market
Holder: BIONTECH MANUFACTURING GMBH
Molecule: TOZINAMERAN

Health Canada record

Active ingredient(s)TOZINAMERAN 15 MCG; RILTOZINAMERAN 15 MCG
Dosage formSuspension
RouteIntramuscular
ScheduleSCHEDULE D
ClassHuman
ATCJ07BN01 COVID-19, RNA-BASED VACCINE
Original market date
Current status date03-May-2024
SourceHealth Canada DPD

Establishment licence of the holder

BioNTech Manufacturing Marburg GmbH — licence , not currently licensed, last inspection rating C (2024-09-04).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing TOZINAMERAN

DINProductCompanyFormStrengthStatus
02509210COMIRNATYBIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 30 MCGCancelled Post Market
02522454COMIRNATYBIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 10 MCGCancelled Post Market
02527863COMIRNATYBIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 30 MCGCancelled Post Market
02530325COMIRNATYBIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 3 MCGCancelled Post Market
02531461COMIRNATY ORIGINAL & OMICRON BA.4/BA.5BIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 15 MCG; FAMTOZINAMERAN 15 MCGCancelled Post Market
02533197COMIRNATY ORIGINAL & OMICRON BA.4/BA.5BIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 5 MCG; FAMTOZINAMERAN 5 MCGCancelled Post Market
02541025COMIRNATY ORIGINAL & OMICRON BA.4/BA.5BIONTECH MANUFACTURING GMBHSuspensionTOZINAMERAN 1.5 MCG; FAMTOZINAMERAN 1.5 MCGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
292742022-10-21New Drug Submission (NDS)
Request a quote for COMIRNATY ORIGINAL/OMICRON BA.1

How to read a Canadian DIN record